FluidForm Bio
Waltham · Founded 2018
About FluidForm Bio
FluidForm Bio™ is creating living human tissue for better treatment of disease. Our patented FRESH™ technology is a revolutionary platform designed to build tissue using cells, proteins, and nothing else. Through partnerships with top life science companies, our technology has been validated to produce the highest quality tissue in a variety of applications. We deliver human tissue that is indistinguishable from the real thing by integrating breakthrough innovations in 3D printing, computational and synthetic biology, AI, and advanced materials science. Our living tissue will offer therapies to countless patients who deserve better treatment options. FluidForm Bio™was founded in 2018 on the belief that the world needs transformational technologies led by creative and passionate experts that help people lead better lives. Headquartered in Waltham, MA.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $499.6K
- Last round: Series Unknown (Jan 2022)
- Website: https://www.fluidformbio.com
- Phone: [email protected]
Industries & Categories
3D Printing, 3D Technology, Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/fluidform-bio-113949 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.